Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Savani

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Bone Marrow Transplantation|March 31, 2015
Secondary solid cancer screening following hematopoietic cell transplantationY Inamoto, N N Shah, B N Savani, et al.
Bone Marrow Transplantation|August 4, 2015
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphomaP Satwani, K W Ahn, J Carreras, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Bone Marrow Transplantation|March 31, 2015
Secondary solid cancer screening following hematopoietic cell transplantationY Inamoto, N N Shah, B N Savani, et al.
Bone Marrow Transplantation|August 4, 2015
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphomaP Satwani, K W Ahn, J Carreras, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 6